Skip to main content
Top
Published in: Malaria Journal 1/2016

Open Access 01-12-2016 | Research

Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine

Authors: Bo Huang, Qi Wang, Changsheng Deng, Jianhua Wang, Tao Yang, Shiguang Huang, Xin-zhuan Su, Yajun Liu, Longhua Pan, Guoming Li, Di Li, Hongying Zhang, Afane Bacar, Kamal Said Abdallah, Rachad Attoumane, Ahamada M. S. A. Mliva, Shaoqin Zheng, Qin Xu, Fangli Lu, Yezhi Guan, Jianping Song

Published in: Malaria Journal | Issue 1/2016

Login to get access

Abstract

Background

In Comoros, the widespread of chloroquine (CQ)-resistant Plasmodium falciparum populations was a major obstacle to malaria control, which led to the official withdrawal of CQ in 2004. Continuous monitoring of CQ-resistant markers of the P. falciparum CQ resistant transporter (pfcrt) and the P. falciparum multiple drug resistance 1 (pfmdr-1) is necessary inder to obtain first-hand information on CQ susceptibility of parasite populations in the field. The objective of this study is to assess the prevalence and evolution of CQ-resistance in the P. falciparum populations on the Comoros’ Grande Comore island after withdrawal of CQ.

Methods

A total of 207 P. falciparum clinical isolates were collected from the island, including 118 samples from 2006 to 2007 and 89 samples from 2013 to 2014. Nucleotide substitutions in the pfcrt and pfmdr-1 genes linked to CQ response in parasite isolates were assessed using nested PCR and DNA sequencing.

Results

From the pfcrt gene segment sequenced, we detected C72S, M74I, N75E, and K76T substitutions in the parasite isolates collected from both 20062007 to 20132014 periods. Significant decline of pfcrt resistant alleles at C72S (42.6 to 6.9 %), M74I (39.1 to 14.9 %), N75E (63.5 to 18.3 %), and K76T (72.2 to 19.5 %) from 2006–2007 to 2013–2014 were observed, and the frequency of pfcrt wild type allele was significantly increased from 19.1 % in 2006–2007 to 75.8 % in 2013–2014. Sequence analysis of pfmdr-1 also detected point mutations at codons N86Y, Y184F, and D1246Y, but not S1034C and N1042D, in the isolates collected from both examined periods. An increasing trend in the prevalence of the pfmdr-1 wild type allele (NYD, 4.3 % in 2006–2007; and 28.7 % in 2013–2014), and a decreasing trend for pfmdr-1 N86Y mutation (87.0 % in 2006–2007; and 40.2 % in 2013–2014) were observed in our samples.

Conclusions

The present data indicate that the prevalence and patterns of mutant pfcrt and pfmdr-1 dramatically decreased in the Grande Comore isolates from 2006 to 2014, suggesting that the CQ-sensitive P. falciparum strains have returned after the withdrawal of CQ. The data also suggests that the parasites with wild type pfcrt/pfdmr-1 genes may have growth and/or transmission advantages over the mutant parasites. The information obtained from this study will be useful for developing and updating anti-malarial treatment policy in Grande Comore island.
Literature
1.
go back to reference WHO. World malaria report 2015. Geneva: World Health Organization; 2015. WHO. World malaria report 2015. Geneva: World Health Organization; 2015.
2.
go back to reference Ouledi A. Epidemiology and control of malaria in the Federal Islamic Republic of Comoros. Sante. 1995;5:368–71.PubMed Ouledi A. Epidemiology and control of malaria in the Federal Islamic Republic of Comoros. Sante. 1995;5:368–71.PubMed
3.
go back to reference WHO. Global report on antimalarial drug efficacy and drug resistance 2000–2010. Geneva: World Health Organization; 2010. WHO. Global report on antimalarial drug efficacy and drug resistance 2000–2010. Geneva: World Health Organization; 2010.
4.
go back to reference Eichenlaub D, Pohle H. A case of chloroquine-resistant (R1) falciparum malaria from the East African Comoros Islands (in German. Infection. 1980;8:90–2.CrossRefPubMed Eichenlaub D, Pohle H. A case of chloroquine-resistant (R1) falciparum malaria from the East African Comoros Islands (in German. Infection. 1980;8:90–2.CrossRefPubMed
5.
go back to reference Feillet N, Agnamey P, Brasseur P, Druilhe P. In vivo resistance of Plasmodium falciparum to chloroquine in Anjouan (Comoros) (in French). Bull Soc Pathol Exot. 1993;86:48–51.PubMed Feillet N, Agnamey P, Brasseur P, Druilhe P. In vivo resistance of Plasmodium falciparum to chloroquine in Anjouan (Comoros) (in French). Bull Soc Pathol Exot. 1993;86:48–51.PubMed
6.
go back to reference Blanchy S, Julvez J, Mouchet J. Epidemiological stratification of malaria in the Comoro archipelago (in French). Bull Soc Pathol Exot. 1999;92:177–84.PubMed Blanchy S, Julvez J, Mouchet J. Epidemiological stratification of malaria in the Comoro archipelago (in French). Bull Soc Pathol Exot. 1999;92:177–84.PubMed
7.
go back to reference Ariey F, Randrianarivelojosia M, Duchemin J, Rakotondramarina D, Ouledi A, Robert V, et al. Mapping of a Plasmodium falciparum Pfcrt K76T mutation: a useful strategy for controlling chloroquine resistance in Madagascar. J Infect Dis. 2002;185:710–2.CrossRefPubMed Ariey F, Randrianarivelojosia M, Duchemin J, Rakotondramarina D, Ouledi A, Robert V, et al. Mapping of a Plasmodium falciparum Pfcrt K76T mutation: a useful strategy for controlling chloroquine resistance in Madagascar. J Infect Dis. 2002;185:710–2.CrossRefPubMed
8.
go back to reference Phyo A, Nkhoma S, Stepniewska K, Ashley E, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960–6.CrossRefPubMedPubMedCentral Phyo A, Nkhoma S, Stepniewska K, Ashley E, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960–6.CrossRefPubMedPubMedCentral
9.
go back to reference Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–5.CrossRefPubMed Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–5.CrossRefPubMed
10.
go back to reference Ashley E, Dhorda M, Fairhurst R, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411–23.CrossRefPubMedPubMedCentral Ashley E, Dhorda M, Fairhurst R, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411–23.CrossRefPubMedPubMedCentral
11.
go back to reference Huang B, Deng C, Yang T, Xue L, Wang Q, Huang S, et al. Polymorphisms of the artemisinin resistant (K13) in Plasmodium falciparum parasite populations of Grande Comore island 10 years after artemisinin combination therapy. Parasite Vectors. 2015;8:634.CrossRef Huang B, Deng C, Yang T, Xue L, Wang Q, Huang S, et al. Polymorphisms of the artemisinin resistant (K13) in Plasmodium falciparum parasite populations of Grande Comore island 10 years after artemisinin combination therapy. Parasite Vectors. 2015;8:634.CrossRef
12.
go back to reference Torrentino-Madamet M, Collet L, Lepère J, Benoit N, Amalvict R, Ménard D, et al. K13-propeller polymorphisms in Plasmodium falciparum isolates from patients in Mayotte in 2013 and 2014. Antimicrob Agents Chemother. 2015;59:7878–81.CrossRefPubMedPubMedCentral Torrentino-Madamet M, Collet L, Lepère J, Benoit N, Amalvict R, Ménard D, et al. K13-propeller polymorphisms in Plasmodium falciparum isolates from patients in Mayotte in 2013 and 2014. Antimicrob Agents Chemother. 2015;59:7878–81.CrossRefPubMedPubMedCentral
13.
go back to reference Reed M, Saliba K, Caruana S, Kirk K, Cowman A. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 2000;403:906–9.CrossRefPubMed Reed M, Saliba K, Caruana S, Kirk K, Cowman A. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 2000;403:906–9.CrossRefPubMed
14.
go back to reference Djimde A, Doumbo O, Cortese J, Kayentao K, Doumbo S, Diourte Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Eng J Med. 2001;344:257–63.CrossRef Djimde A, Doumbo O, Cortese J, Kayentao K, Doumbo S, Diourte Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Eng J Med. 2001;344:257–63.CrossRef
15.
go back to reference Kublin J, Cortese J, Njunju E, Mukadam R, Wirima J, Kazembe P, et al. Reemergence of chloroquine sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003;187:1870–5.CrossRefPubMed Kublin J, Cortese J, Njunju E, Mukadam R, Wirima J, Kazembe P, et al. Reemergence of chloroquine sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis. 2003;187:1870–5.CrossRefPubMed
16.
go back to reference Nsanzabana C, Hastings I, Marfurt J, Müller I, Baea K, Rare L, et al. Quantifying the evolution and impact of antimalarial drug resistance: drug use, spread of resistance, and drug failure over a 12-year period in Papua New Guinea. J Infect Dis. 2010;201:435–43.CrossRefPubMed Nsanzabana C, Hastings I, Marfurt J, Müller I, Baea K, Rare L, et al. Quantifying the evolution and impact of antimalarial drug resistance: drug use, spread of resistance, and drug failure over a 12-year period in Papua New Guinea. J Infect Dis. 2010;201:435–43.CrossRefPubMed
17.
go back to reference Frank M, Lehners N, Mayengue P, Gabor J, Dal-Bianco M, Kombila D, et al. A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon. Malar J. 2011;10:304.CrossRefPubMedPubMedCentral Frank M, Lehners N, Mayengue P, Gabor J, Dal-Bianco M, Kombila D, et al. A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon. Malar J. 2011;10:304.CrossRefPubMedPubMedCentral
18.
go back to reference Nwakanma D, Duffy C, Amambua-Ngwa A, Oriero E, Bojang K, Pinder M, et al. Changes in malaria parasite drug resistance in an endemic population over a 25-year period with resulting genomic evidence of selection. J Infect Dis. 2014;209:1126–35.CrossRefPubMed Nwakanma D, Duffy C, Amambua-Ngwa A, Oriero E, Bojang K, Pinder M, et al. Changes in malaria parasite drug resistance in an endemic population over a 25-year period with resulting genomic evidence of selection. J Infect Dis. 2014;209:1126–35.CrossRefPubMed
19.
go back to reference Mwai L, Ochong E, Abdirahman A, Kiara S, Ward S, Kokwaro G, et al. Chloroquine resistance before and after its withdrawal in Kenya. Malar J. 2009;8:106.CrossRefPubMedPubMedCentral Mwai L, Ochong E, Abdirahman A, Kiara S, Ward S, Kokwaro G, et al. Chloroquine resistance before and after its withdrawal in Kenya. Malar J. 2009;8:106.CrossRefPubMedPubMedCentral
20.
go back to reference Laufer M, Takala-Harrison S, Dzinjalamala F, Stine O, Taylor T, Plowe C. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. J Infect Dis. 2010;202:801–8.CrossRefPubMedPubMedCentral Laufer M, Takala-Harrison S, Dzinjalamala F, Stine O, Taylor T, Plowe C. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. J Infect Dis. 2010;202:801–8.CrossRefPubMedPubMedCentral
21.
go back to reference Laufer M, Thesing P, Eddington N, Masonga R, Dzinjalamala F, Takala S, et al. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med. 2006;355:1959–66.CrossRefPubMed Laufer M, Thesing P, Eddington N, Masonga R, Dzinjalamala F, Takala S, et al. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med. 2006;355:1959–66.CrossRefPubMed
22.
go back to reference Mekonnen S, Aseffa A, Berhe N, Teklehaymanot T, Clouse R, Gebru T, et al. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia. Malar J. 2014;13:244.CrossRefPubMedPubMedCentral Mekonnen S, Aseffa A, Berhe N, Teklehaymanot T, Clouse R, Gebru T, et al. Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia. Malar J. 2014;13:244.CrossRefPubMedPubMedCentral
23.
go back to reference Mohammed A, Ndaro A, Kalinga A, Manjurano A, Mosha J, Mosha D, et al. Trends in chloroquine resistance marker, Pfcrt-K76T mutation 10 years after chloroquine withdrawal in Tanzania. Malar J. 2013;12:415.CrossRefPubMedPubMedCentral Mohammed A, Ndaro A, Kalinga A, Manjurano A, Mosha J, Mosha D, et al. Trends in chloroquine resistance marker, Pfcrt-K76T mutation 10 years after chloroquine withdrawal in Tanzania. Malar J. 2013;12:415.CrossRefPubMedPubMedCentral
24.
go back to reference Ogouyèmi-Hounto A, Ndam N, Kinde Gazard D, d’Almeida S, Koussihoude L, Ollo E, et al. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin 7 years after the change of malaria treatment policy. Malar J. 2013;12:147.CrossRefPubMedPubMedCentral Ogouyèmi-Hounto A, Ndam N, Kinde Gazard D, d’Almeida S, Koussihoude L, Ollo E, et al. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin 7 years after the change of malaria treatment policy. Malar J. 2013;12:147.CrossRefPubMedPubMedCentral
25.
go back to reference Inoue J, Lopes D, Rosario V, Machado M, Hristov A, Lima G, et al. Analysis of polymorphisms in Plasmodium falciparum genes related to drug resistance: a survey over four decades under different treatment policies in Brazil. Malar J. 2014;13:372.CrossRefPubMedPubMedCentral Inoue J, Lopes D, Rosario V, Machado M, Hristov A, Lima G, et al. Analysis of polymorphisms in Plasmodium falciparum genes related to drug resistance: a survey over four decades under different treatment policies in Brazil. Malar J. 2014;13:372.CrossRefPubMedPubMedCentral
26.
go back to reference Randrianarivelojosia M, Raherinjafy R, Migliani R, Mercereau-Puijalon O, Ariey F, Bedja S. Plasmodium falciparum resistant to chloroquine and to pyrimethamine in Comoros. Parasite. 2004;11:419–23.CrossRefPubMed Randrianarivelojosia M, Raherinjafy R, Migliani R, Mercereau-Puijalon O, Ariey F, Bedja S. Plasmodium falciparum resistant to chloroquine and to pyrimethamine in Comoros. Parasite. 2004;11:419–23.CrossRefPubMed
27.
go back to reference Silai R, Moussa M, Abdalli M, Astafieva-Djaza M, Hafidhou M, Oumadi A, et al. Surveillance of falciparum malaria susceptibility to antimalarial drugs and policy change in the Comoros (in French). Bull Soc Pathol Exot. 2007;100:6–9.CrossRefPubMed Silai R, Moussa M, Abdalli M, Astafieva-Djaza M, Hafidhou M, Oumadi A, et al. Surveillance of falciparum malaria susceptibility to antimalarial drugs and policy change in the Comoros (in French). Bull Soc Pathol Exot. 2007;100:6–9.CrossRefPubMed
28.
go back to reference Parola P, Pradines B, Gazin P, Keundjian A, Silai R, Parzy D. Chemosusceptibility analysis of Plasmodium falciparum imported from Comoros to Marseilles, France in 2001–2003. Med Mal Infect. 2005;35:489–91.CrossRefPubMed Parola P, Pradines B, Gazin P, Keundjian A, Silai R, Parzy D. Chemosusceptibility analysis of Plasmodium falciparum imported from Comoros to Marseilles, France in 2001–2003. Med Mal Infect. 2005;35:489–91.CrossRefPubMed
29.
go back to reference Menard D, Randrianarivo-Solofoniaina A, Ahmed B, Jahevitra M, Andriantsoanirina V, Rasolofomanana R, et al. Drug-resistant malaria parasites introduced into Madagascar from Comoros islands. Emerg Infect Dis. 2007;13:1759–62.CrossRefPubMedPubMedCentral Menard D, Randrianarivo-Solofoniaina A, Ahmed B, Jahevitra M, Andriantsoanirina V, Rasolofomanana R, et al. Drug-resistant malaria parasites introduced into Madagascar from Comoros islands. Emerg Infect Dis. 2007;13:1759–62.CrossRefPubMedPubMedCentral
30.
go back to reference Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Jahevitra M, Rabearimanana A, Radrianjafy R, et al. Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrob Agents Chemother. 2009;53:4588–97.CrossRefPubMedPubMedCentral Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Jahevitra M, Rabearimanana A, Radrianjafy R, et al. Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrob Agents Chemother. 2009;53:4588–97.CrossRefPubMedPubMedCentral
31.
go back to reference Rebaudet S, Bogreau H, Silaï R, Lepère J, Bertaux L, Pradines B, et al. Genetic structure of Plasmodium falciparum and elimination of malaria, Comoros archipelago. Emerg Infect Dis. 2010;16:1686–94.CrossRefPubMedPubMedCentral Rebaudet S, Bogreau H, Silaï R, Lepère J, Bertaux L, Pradines B, et al. Genetic structure of Plasmodium falciparum and elimination of malaria, Comoros archipelago. Emerg Infect Dis. 2010;16:1686–94.CrossRefPubMedPubMedCentral
32.
go back to reference Plowe C, Wellems T. Detection of mutations in a putative Plasmodium falciparum transporter linked to chloroquine resistance. Report for the WHO workshop on markers of antimalarial drug resistance; 1999. Plowe C, Wellems T. Detection of mutations in a putative Plasmodium falciparum transporter linked to chloroquine resistance. Report for the WHO workshop on markers of antimalarial drug resistance; 1999.
33.
go back to reference Duah N, Matrevi S, de Souza D, Binnah D, Tamakloe M, Opoku V, et al. Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy. Malar J. 2013;12:377.CrossRefPubMedPubMedCentral Duah N, Matrevi S, de Souza D, Binnah D, Tamakloe M, Opoku V, et al. Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy. Malar J. 2013;12:377.CrossRefPubMedPubMedCentral
34.
go back to reference Wurtz N, Fall B, Pascual A, Diawara S, Sow K, Baret E, et al. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal. Malar J. 2012;11:197.CrossRefPubMedPubMedCentral Wurtz N, Fall B, Pascual A, Diawara S, Sow K, Baret E, et al. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal. Malar J. 2012;11:197.CrossRefPubMedPubMedCentral
35.
go back to reference Raman J, Mauff K, Muianga P, Mussa A, Maharaj R, Barnes K. Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out. PLoS ONE. 2011;6:e25992.CrossRefPubMed Raman J, Mauff K, Muianga P, Mussa A, Maharaj R, Barnes K. Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out. PLoS ONE. 2011;6:e25992.CrossRefPubMed
36.
go back to reference Deloron P, Le Bras J, Ramanamirija J, Coulanges P. Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs. Ann Trop Med Parasitol. 1985;79:357–65.PubMed Deloron P, Le Bras J, Ramanamirija J, Coulanges P. Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs. Ann Trop Med Parasitol. 1985;79:357–65.PubMed
37.
go back to reference Maïga-Ascofaré O, Rakotozandrindrainy R, Girmann M, Hahn A, Randriamampionona N, Poppert S, et al. Molecular epidemiology and seroprevalence in asymptomatic Plasmodium falciparum infections of Malagasy pregnant women in the highlands. Malar J. 2015;4:188.CrossRef Maïga-Ascofaré O, Rakotozandrindrainy R, Girmann M, Hahn A, Randriamampionona N, Poppert S, et al. Molecular epidemiology and seroprevalence in asymptomatic Plasmodium falciparum infections of Malagasy pregnant women in the highlands. Malar J. 2015;4:188.CrossRef
38.
go back to reference Sisowath C, Petersen I, Veiga M, Martensson A, Premji Z, Bjorkman A, et al. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. J Infect Dis. 2009;199:750–7.CrossRefPubMedPubMedCentral Sisowath C, Petersen I, Veiga M, Martensson A, Premji Z, Bjorkman A, et al. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. J Infect Dis. 2009;199:750–7.CrossRefPubMedPubMedCentral
39.
go back to reference Henriques G, Hallett R, Beshir K, Gadalla N, Johnson R, Burrow R, et al. Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT. J Infect Dis. 2014;210:2001–8.CrossRefPubMedPubMedCentral Henriques G, Hallett R, Beshir K, Gadalla N, Johnson R, Burrow R, et al. Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT. J Infect Dis. 2014;210:2001–8.CrossRefPubMedPubMedCentral
40.
go back to reference Jiang H, Patel J, Yi M, Mu J, Ding J, Stephens R, et al. Genome-wide compensatory changes accompany drug-selected mutations in the Plasmodium falciparum crt gene. PLoS ONE. 2008;3:e2484.CrossRefPubMedPubMedCentral Jiang H, Patel J, Yi M, Mu J, Ding J, Stephens R, et al. Genome-wide compensatory changes accompany drug-selected mutations in the Plasmodium falciparum crt gene. PLoS ONE. 2008;3:e2484.CrossRefPubMedPubMedCentral
41.
go back to reference Levin B, Perrot V, Walker N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics. 2000;154:985–97.PubMedPubMedCentral Levin B, Perrot V, Walker N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics. 2000;154:985–97.PubMedPubMedCentral
42.
go back to reference Sa J, Twu O. Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the Pfcrt SVMNT type. Malar J. 2010;9:374.CrossRefPubMedPubMedCentral Sa J, Twu O. Protecting the malaria drug arsenal: halting the rise and spread of amodiaquine resistance by monitoring the Pfcrt SVMNT type. Malar J. 2010;9:374.CrossRefPubMedPubMedCentral
43.
go back to reference Vathsala P, Pramanik A, Dhanasekaran S, Devi C, Pillai C, Subbarao S, et al. Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMNT in P. falciparum malaria in India. Am J Trop Med Hyg. 2004;70:256–9.PubMed Vathsala P, Pramanik A, Dhanasekaran S, Devi C, Pillai C, Subbarao S, et al. Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMNT in P. falciparum malaria in India. Am J Trop Med Hyg. 2004;70:256–9.PubMed
44.
go back to reference Awasthi G, Prasad G, Das A. Population genetic analyses of Plasmodium falciparum chloroquine receptor transporter gene haplotypes reveal the evolutionary history of chloroquine-resistant malaria in India. Int J Parasitol. 2011;41:705–9.CrossRefPubMed Awasthi G, Prasad G, Das A. Population genetic analyses of Plasmodium falciparum chloroquine receptor transporter gene haplotypes reveal the evolutionary history of chloroquine-resistant malaria in India. Int J Parasitol. 2011;41:705–9.CrossRefPubMed
45.
go back to reference Dittrich S, Alifrangis M, Stohrer J, Thongpaseuth V, Vanisaveth V, Phetsouvanh R, et al. Falciparum malaria in the north of Laos: the occurrence and implications of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT. Trop Med Int Health. 2005;10:1267–70.CrossRefPubMed Dittrich S, Alifrangis M, Stohrer J, Thongpaseuth V, Vanisaveth V, Phetsouvanh R, et al. Falciparum malaria in the north of Laos: the occurrence and implications of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT. Trop Med Int Health. 2005;10:1267–70.CrossRefPubMed
46.
go back to reference Fidock A, Nomura T, Talley K, Cooper A, Dzekunov M, Ferdig T, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein Pfcrt and evidence for their role in chloroquine resistance. Mol Cell. 2000;6:861–71.CrossRefPubMedPubMedCentral Fidock A, Nomura T, Talley K, Cooper A, Dzekunov M, Ferdig T, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein Pfcrt and evidence for their role in chloroquine resistance. Mol Cell. 2000;6:861–71.CrossRefPubMedPubMedCentral
47.
go back to reference Cooper R, Hartwig C, Ferdig M. pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective. Acta Trop. 2005;94:170–80.CrossRefPubMed Cooper R, Hartwig C, Ferdig M. pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective. Acta Trop. 2005;94:170–80.CrossRefPubMed
48.
go back to reference Alifrangis M, Dalgaard M, Lusingu J, Vestergaard L, Staalsoe T, Jensen A, et al. Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. J Infect Dis. 2006;193:1738–41.CrossRefPubMed Alifrangis M, Dalgaard M, Lusingu J, Vestergaard L, Staalsoe T, Jensen A, et al. Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. J Infect Dis. 2006;193:1738–41.CrossRefPubMed
49.
go back to reference Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Tichit M, Jahevitra M, Rabearimanana S, et al. Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar. PLoS ONE. 2010;5:e13281.CrossRefPubMedPubMedCentral Andriantsoanirina V, Ratsimbasoa A, Bouchier C, Tichit M, Jahevitra M, Rabearimanana S, et al. Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar. PLoS ONE. 2010;5:e13281.CrossRefPubMedPubMedCentral
50.
go back to reference Rason M, Andrianantenaina H, Ariey F, Raveloson A, Domarle O, Randrianarivelojosia M. Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains. Am J Trop Med Hyg. 2007;76:1079–83.PubMed Rason M, Andrianantenaina H, Ariey F, Raveloson A, Domarle O, Randrianarivelojosia M. Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains. Am J Trop Med Hyg. 2007;76:1079–83.PubMed
51.
go back to reference Dokomajilar C, Nsobya S, Greenhouse B, Rosenthal P, Dorsey G. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob Agents Chemother. 2006;50:1893–5.CrossRefPubMedPubMedCentral Dokomajilar C, Nsobya S, Greenhouse B, Rosenthal P, Dorsey G. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob Agents Chemother. 2006;50:1893–5.CrossRefPubMedPubMedCentral
52.
go back to reference Gadalla N, Adam I, Elzaki S, Bashir S, Mukhtar I, Oguike M, et al. Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine. Antimicrob Agents Chemother. 2011;55:5408–11.CrossRefPubMedPubMedCentral Gadalla N, Adam I, Elzaki S, Bashir S, Mukhtar I, Oguike M, et al. Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine. Antimicrob Agents Chemother. 2011;55:5408–11.CrossRefPubMedPubMedCentral
Metadata
Title
Prevalence of crt and mdr-1 mutations in Plasmodium falciparum isolates from Grande Comore island after withdrawal of chloroquine
Authors
Bo Huang
Qi Wang
Changsheng Deng
Jianhua Wang
Tao Yang
Shiguang Huang
Xin-zhuan Su
Yajun Liu
Longhua Pan
Guoming Li
Di Li
Hongying Zhang
Afane Bacar
Kamal Said Abdallah
Rachad Attoumane
Ahamada M. S. A. Mliva
Shaoqin Zheng
Qin Xu
Fangli Lu
Yezhi Guan
Jianping Song
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2016
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-016-1474-4

Other articles of this Issue 1/2016

Malaria Journal 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.